Tazalok drops oral solution bottle 100 ml

A herbal non-hormonal preparation with a complex action, which is due to the synergistic effects of the components that make up the preparation and have hormone-regulating, anti-proliferative, anti-inflammatory, sedative and tonic effects. Flavonoids of biologically active substances of the preparation Tazalok are similar in structure to endogenous estrogen, but do not exhibit estrogen-like activity, they have the ability to competitively bind to estrogen (androgen) receptors with an excess of estrogens (androgens) or receptors for them in target organs, change the activity of aromatase system enzymes, preventing the conversion of androgens into estrogens. Thus, Tazalok exhibits selective anti-estrogenic activity, leads to rhythmic production and normalization of the ratio of gonadotropic hormones, helps to reduce prolactin levels and increase progesterone levels, eliminates the imbalance between estradiol and progesterone, normalizes the second phase of the menstrual cycle. has a pronounced effect on the glandular tissue and stromal elements of the mammary glands, ovaries and uterus, exhibits antiproliferative and anti-inflammatory properties, prevents the development of dysplastic processes in these tissues. in polycystic ovarian lesions, it helps soften the cyst capsule, reduce its tension due to the resorptive effect, and enhance the function of the intact part of the ovary. promotes the active development of cyst contents, resorption of painless dense nodes in the mammary glands, reduces the reaction of the mammary glands to the phases of the menstrual cycle. exhibits antispasmodic properties, has an analgesic and sedative effect. biologically active molecules of the drug Tazalok have the ability to induce and enhance apoptosis, block the action of growth factors, and inhibit angiogenesis.

Menstrual cycle disorders, premenstrual syndrome, algodysmenorrhea, dysmenorrhea, fibrocystic mastopathy, ovarian retention cysts. as part of complex therapy for endometrial hyperplasia, uterine fibroids, endometriosis, polycystic ovary syndrome.

Dilute 30-40 drops of the drug in ½ cup of boiled water at room temperature.

Take 30 minutes before meals 3 times a day. The course of treatment is at least 3 months, without interrupting the intake during menstruation. The daily dose can be divided into 2 doses. If after stopping the drug, symptoms reappear, therapy should be continued after consulting a doctor.

Hypersensitivity to the components of the drug.

On the skin, hypersensitivity reactions and allergic reactions may sometimes occur, including skin rashes, hyperemia, itching, skin edema, and infiltrated hyperemic spots.

If any adverse reactions occur, you should stop using the drug and be sure to consult a doctor.

Do not use during pregnancy and breastfeeding.

Children: The drug should not be used in children because the efficacy and safety of the drug in children have not been established.

The ability to influence the reaction speed when driving vehicles or working with other mechanisms. Does not affect.

If you need to use any other medications, you should inform your doctor.

Cases of overdose of the drug are unlikely, however, cardiovascular system disorders may occur.

Treatment: gastric lavage, administration of activated charcoal, symptomatic therapy.

In the original packaging at a temperature not exceeding 25 °C.